[ Price : $8.95]
Federal Register Notice: FDA asks for comments on a submission to OMB seeking to extend an information collection related to Inves...[ Price : $8.95]
FDA urges the public and industry insiders to report regulatory misconduct against medical device manufacturers or individuals mar...[ Price : $8.95]
Federal Register Notice: FDA and CMS announce their intention to fully implement their joint parallel review pilot program.[ Price : $8.95]
Federal Register Notice: FDA asks for comments on a submission to OMB seeking to extend an information collection related to a gui...[ Price : $8.95]
FDA and CMS announce that their ongoing medical device parallel review pilot program will be fully implemented and extended indefi...[ Price : $8.95]
In response to another Star Tribune article questioning late medical device reporting to FDA, Sen. Al Franken (D-MN) says he conti...[ Price : $8.95]
FDA approves an Astellas Pharma and Pfizer supplemental NDA to change product labeling for Xtandi (enzalutamide) capsules to inclu...[ Price : $8.95]
Newron Pharmaceuticals resubmits an NDA for safinamide, indicated for treating patients with Parkinsons disease.